G. Brenning

829 total citations
21 papers, 502 citations indexed

About

G. Brenning is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, G. Brenning has authored 21 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in G. Brenning's work include Multiple Myeloma Research and Treatments (13 papers), Peptidase Inhibition and Analysis (4 papers) and Glycosylation and Glycoproteins Research (3 papers). G. Brenning is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Peptidase Inhibition and Analysis (4 papers) and Glycosylation and Glycoproteins Research (3 papers). G. Brenning collaborates with scholars based in Sweden and Canada. G. Brenning's co-authors include A. Åhre, Kenneth Nilsson, Bengt Simonsson, Shahin Abdsaleh, Clas F. R. Källander, Magnus Björkholm, Gösta Gahrton, Hans Gyllenhammar, A. Killander and Robert Hast and has published in prestigious journals such as Blood, British Journal of Haematology and European Journal of Clinical Investigation.

In The Last Decade

G. Brenning

21 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Brenning Sweden 13 298 284 187 74 64 21 502
M Masuda Japan 10 173 0.6× 118 0.4× 70 0.4× 72 1.0× 103 1.6× 22 382
Brian L. Abbott United States 10 105 0.4× 204 0.7× 145 0.8× 89 1.2× 46 0.7× 25 404
A. Covelli Italy 11 134 0.4× 174 0.6× 158 0.8× 95 1.3× 30 0.5× 23 447
Jolanta Libura United States 9 153 0.5× 242 0.9× 200 1.1× 43 0.6× 160 2.5× 13 585
Anna Szmigielska‐Kapłon Poland 16 215 0.7× 151 0.5× 198 1.1× 187 2.5× 103 1.6× 55 570
D Hollard France 13 432 1.4× 118 0.4× 102 0.5× 185 2.5× 82 1.3× 56 612
E. J. E. G. Bast Netherlands 11 118 0.4× 88 0.3× 107 0.6× 42 0.6× 118 1.8× 22 396
Jessica Boklan United States 12 134 0.4× 118 0.4× 215 1.1× 62 0.8× 59 0.9× 30 467
Moore Ma United States 12 351 1.2× 154 0.5× 220 1.2× 114 1.5× 182 2.8× 30 664
Yasunobu Sakai United States 6 326 1.1× 266 0.9× 107 0.6× 68 0.9× 48 0.8× 7 526

Countries citing papers authored by G. Brenning

Since Specialization
Citations

This map shows the geographic impact of G. Brenning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Brenning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Brenning more than expected).

Fields of papers citing papers by G. Brenning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Brenning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Brenning. The network helps show where G. Brenning may publish in the future.

Co-authorship network of co-authors of G. Brenning

This figure shows the co-authorship network connecting the top 25 collaborators of G. Brenning. A scholar is included among the top collaborators of G. Brenning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Brenning. G. Brenning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rundlöf, Torgny, et al.. (2007). Adverse effects by artificial grapefruit seed extract products in patients on warfarin therapy. European Journal of Clinical Pharmacology. 63(6). 565–570. 24 indexed citations
2.
Hallberg, Pär & G. Brenning. (2005). Angioedema induced by tramadol?a potentially life-threatening condition. European Journal of Clinical Pharmacology. 60(12). 901–903. 12 indexed citations
3.
Abdsaleh, Shahin, et al.. (2001). MR IMAGING OF PRIMARY, SECONDARY, AND MIXED FORMS OF LYMPHEDEMA. Acta Radiologica. 42(4). 409–416. 40 indexed citations
4.
Abdsaleh, Shahin, et al.. (2001). MR imaging of primary, secondary, and mixed forms of lymphedema. Acta Radiologica. 42(4). 409–416. 33 indexed citations
5.
6.
7.
Sundström, Christer, Kenneth Nilsson, & G. Brenning. (1988). IgE‐producing low‐grade non‐Hodgkin lymphoma. European Journal Of Haematology. 41(4). 388–395. 1 indexed citations
8.
Simonsson, Bengt, Clas F. R. Källander, G. Brenning, et al.. (1988). Biochemical markers in multiple myeloma: a multivariate analysis. British Journal of Haematology. 69(1). 47–53. 16 indexed citations
9.
Simonsson, Bengt, G. Brenning, Clas F. R. Källander, & A. Åhre. (1987). Prognostic value of serum lactic dehydrogenase (S‐LDH) in multiple myeloma. European Journal of Clinical Investigation. 17(4). 336–339. 33 indexed citations
10.
Brenning, G., et al.. (1987). Influence of interferon on the growth of primary ovarian carcinoma cells in a semi-solid agar system: Comparison with clinical effects of interferon therapy. Medical Oncology and Tumor Pharmacotherapy. 4(2). 81–86. 2 indexed citations
11.
12.
Brenning, G., A. Åhre, & Kenneth Nilsson. (1985). Correlation between in vitro and in vivo sensitivity to human leucocyte interferon in patients with multiple myeloma. Scandinavian Journal of Haematology. 35(5). 543–549. 54 indexed citations
13.
Simonsson, Bengt, Clas F. R. Källander, G. Brenning, et al.. (1985). Evaluation of serum deoxythymidine kinase as a marker in multiple myeloma. British Journal of Haematology. 61(2). 215–224. 34 indexed citations
14.
Brenning, G., L Wibell, & R. Bergström. (1985). Serum β2‐microglobulin at remission and relapse in patients with multiple myeloma. European Journal of Clinical Investigation. 15(5). 242–247. 10 indexed citations
15.
Brenning, G.. (1985). The in vitro effect of leucocyte α‐interferon on human myeloma cells in a semisolid agar culture system. Scandinavian Journal of Haematology. 35(2). 178–185. 37 indexed citations
16.
Brenning, G.. (1985). Studies on multiple myeloma in vivo and in vitro. 1 indexed citations
17.
Åhre, A., Magnus Björkholm, Håkan Mellstedt, et al.. (1984). Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden.. PubMed. 68(11). 1331–8. 46 indexed citations
18.
Åhre, A., Magnus Björkholm, Håkan Mellstedt, et al.. (1983). Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myeloma. European Journal of Cancer and Clinical Oncology. 19(4). 499–506. 21 indexed citations
19.
Brenning, G., H. Johansson, & T Åberg. (1976). Splenectomy—A Surgical Panorama. Upsala Journal of Medical Sciences. 81(1). 28–30. 1 indexed citations
20.
Udén, A.‐M., G. Brenning, L. Engstedt, et al.. (1975). L‐Asparaginase and Prednisolone Pretreatment Followed by Rubidomycin and Cytosine Arabinoside for Induction of Remission in Adult Patients with Acute Myeloblastic Leukaemia. Scandinavian Journal of Haematology. 15(1). 72–80. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Masuda Breakdown of academic impact, for papers by Brian L. Abbott Breakdown of academic impact, for papers by A. Covelli Breakdown of academic impact, for papers by Jolanta Libura Breakdown of academic impact, for papers by Anna Szmigielska‐Kapłon Breakdown of academic impact, for papers by D Hollard Breakdown of academic impact, for papers by E. J. E. G. Bast Breakdown of academic impact, for papers by Jessica Boklan Breakdown of academic impact, for papers by Moore Ma Breakdown of academic impact, for papers by Yasunobu Sakai
Rankless by CCL
2026